Patrick Frost, PhD

Patrick Frost, PhD

Jan 15, 2016

Group 6 Copy 48
2
Please wait...

About This Project

BBRI and Los Angeles VA Medical Center

Multiple myeloma (MM) is a cancer of the bone marrow made up of plasma cells (a type of antibody-producing white blood cells). Low oxygen levels (called hypoxia) in the bone marrow increases gene expression in MM tumor cells as part of an adaptive survival response. We are targeting this hypoxic response with an experimental drug that blocks expression of these genes to ask if this molecule kills MM in the bone marrow. This is a novel approach to treat MM, an incurable disease.

Blast off!

Browse Other Projects on Experiment

Related Projects

Spiders of Yasuni: How do their Physical Traits Determine their Lifestyle?

There are 40,000+ species of spider in the world. Spiders are beneficial predators & an integral part...

Impacts of a new invasive aphid pest in North America

Through surveys, this project will delineate the expanding range of a new invasive aphid, Metopolophium...

Backer Badge Funded